Oxford Pharmascience Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
5
Active:0
Completed:5
Trial Phases
1 Phases
Phase 1:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (100.0%)Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- Oxford Pharmascience Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT02974361
- Locations
- 🇬🇧
Simbec Orion Ltd, Merthyr Tydfil, United Kingdom
Pilot Study of OXP001(2) and Brufen in Healthy Subjects
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Oxford Pharmascience Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT02521207
- Locations
- 🇬🇧
Quotient Clinical Ltd, Nottingham, Notts, United Kingdom
Pilot Study of OXP005 to Assess Gastroduodenal Irritation
- First Posted Date
- 2015-04-06
- Last Posted Date
- 2015-06-18
- Lead Sponsor
- Oxford Pharmascience Ltd
- Registration Number
- NCT02408978
- Locations
- 🇬🇧
Quotient Clinical Ltd, Nottingham, United Kingdom
Phase I Study PK Study With OXP005 and Naprosyn
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Oxford Pharmascience Ltd
- Registration Number
- NCT02351024
- Locations
- 🇬🇧
Quotient Clinical Ltd, Nottingham, United Kingdom
Pilot Study of OXP001 and Brufen in Healthy Subjects
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2014-04-30
- Lead Sponsor
- Oxford Pharmascience Ltd
- Target Recruit Count
- 43
- Registration Number
- NCT02050958
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, United Kingdom
News
No news found